Лечащий Врач

Расширенный поиск

Немедикаментозные методы лечения и реабилитации пациентов с неалкогольной жировой болезнью печени

Полный текст:


В обзорной статье представлены современные взгляды на возможности организации рациональной диетотерапии, физических нагрузок и модификации образа жизни в ведении пациентов с неалкогольной жировой болезнью печени. Отмечено благоприятное влияние немедикаментозных технологий в длительном ведении и реабилитации пациентов.

Об авторах

В. А. Ахмедов

Н. Ф. Мамедова

Список литературы

1. Pet?j? E. M., Yki-J?rvinen H. Definitions of Normal Liver Fat and the Association of Insulin Sensitivity with Acquired and Genetic NAFLD-A Systematic Review // Int J Mol Sci. 2016; 17: pii: E633.

2. Loria P., Adinolfi L. E., Bellentani S. et al. NAFLD Expert Committee of the Associazione Italiana per lo studio del Fegato. Practice guidelines for the diagnosis and management of nonalcoholic fatty liver disease. A decalogue from the Italian Association for the Study of the Liver (AISF) Expert Committee // Dig Liver Dis. 2010; 42: 272-282.

3. Nascimbeni F., Pais R., Bellentani S. et al. From NAFLD in clinical practice to answers from guidelines // J Hepatol. 2013; 59: 859-871.

4. Lonardo A., Nascimbeni F., Targher G. et al. Italian Association for the Study of the Liver (AISF). AISF position paper on nonalcoholic fatty liver disease (NAFLD): Updates and future directions // Dig Liver Dis. 2017; 49: 471-483.

5. Slagter S. N., van Vliet-Ostaptchouk J. V., Vonk J. M. et al. Combined effects of smoking and alcohol on metabolic syndrome: the LifeLines cohort study // PLoS One. 2014; 9: e96406.

6. Ellison R. C., Zhang Y., Qureshi M. M. et al. Lifestyle determinants of high-density lipoprotein cholesterol: the National Heart, Lung, and Blood Institute Family Heart Study // Am Heart J. 2004; 147: 529-535.

7. Schroder H., Morales-Molina J. A., Bermejo S. et al. Relationship of abdominal obesity with alcohol consumption at population scale // Eur J Nutr. 2007; 46: 369-376.

8. Whitfield J. B., Heath A. C., Madden P. A. et al. Metabolic and biochemical effects of low-to-moderate alcohol consumption // Alcohol Clin Exp Res. 2013; 37: 575-586.

9. Taylor B., Irving H. M., Baliunas D. et al. Alcohol and hypertension: gender differences in dose-response relationships determined through systematic review and meta-analysis // Addiction. 2009; 104: 1981-1990.

10. Koppes L. L., Dekker J. M., Hendriks H. F. et al. Moderate alcohol consumption lowers the risk of type 2 diabetes: a meta-analysis of prospective observational studies // Diabetes Care. 2005; 28: 719-725.

11. Alkerwi A., Boutsen M., Vaillant M. et al. Alcohol consumption and the prevalence of metabolic syndrome: a meta-analysis of observational studies // Atherosclerosis. 2009; 204: 624-635.

12. Freiberg M. S., Cabral H. J., Heeren T. C. et al. Alcohol consumption and the prevalence of the Metabolic Syndrome in the US: a cross-sectional analysis of data from the Third National Health and Nutrition Examination Survey // Diabetes Care. 2004; 27: 2954-2959.

13. Barrio-Lopez M. T., Bes-Rastrollo M., Sayon-Orea C. et al. Different types of alcoholic beverages and incidence of metabolic syndrome and its components in a Mediterranean cohort // Clin Nutr. 2013; 32: 797-804.

14. Audrain-McGovern J., Benowitz N. L. Cigarette smoking, nicotine, and body weight // Clin Pharmacol Ther. 2011; 90: 164-168.

15. Ridker P. M., Buring J. E., Cook N. R. et al. C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women // Circulation. 2003; 107: 391-397.

16. Berlin I., Lin S., Lima J. A. et al. Smoking status and metabolic syndrome in the multi-ethnic study of atherosclerosis. A cross-sectional study // Tob Induc Dis. 2012; 10 (1): 9.

17. Kastorini C. M., Milionis H. J., Esposito K. et al. The effect of Mediterranean diet on metabolic syndrome and its components: a meta-analysis of 50 studies and 534,906 individuals // J Am Coll Cardiol. 2011; 57: 1299-1313.

18. Perez-Martinez P., Garcia-Rios A., Delgado-Lista J. et al. Mediterranean diet rich in olive oil and obesity, metabolic syndrome and diabetes mellitus // Curr Pharm Des. 2011; 17: 769-777.

19. Sola R., La Ville A. E., Richard J. L. et al. Oleic acid rich diet protects against the oxidative modification of high density lipoprotein // Free Radic Biol Med. 1997; 22: 1037-1045.

20. Covas M. I. Olive oil and the cardiovascular system // Pharmacol Res. 2007; 55: 175-186.

21. Sievenpiper J. L., Kendall C. W., Esfahani A. et al. Effect of non-oil-seed pulses on glycaemic control: a systematic review and meta-analysis of randomised controlled experimental trials in people with and without diabetes // Diabetologia. 2009; 52: 1479-1495.

22. Sajjadi F., Gharipour M., Mohammadifard N. et al. Relationship between legumes consumption and metabolic syndrome: findings of the Isfahan Healthy Heart Program // ARYA Atheroscler. 2014; 10: 18-24.

23. Streppel M. T., Arends L. R., van ‘t Veer P. et al. Dietary fiber and blood pressure: a meta-analysis of randomized placebo-controlled trials // Arch Intern Med. 2005; 165: 150-156.

24. Hosseinpour-Niazi S., Mirmiran P., Sohrab G. et al. Inverse association between fruit, legume, and cereal fiber and the risk of metabolic syndrome: Tehran Lipid and Glucose Study // Diabetes Res Clin Pract. 2011; 94: 276-283.

25. Hosseinpour-Niazi S., Mirmiran P., Mirzaei S. et al. Cereal, fruit and vegetable fibre intake and the risk of the metabolic syndrome: a prospective study in the Tehran Lipid and Glucose Study // J Hum Nutr Diet. 2015; 28: 236-245.

26. Turner-McGrievy G., Harris M. Key elements of plant-based diets associated with reduced risk of metabolic syndrome // Curr Diab Rep. 2014; 14: 524.

27. Wallace I. R., McEvoy C. T., Hunter S. J. et al. Dose-response effect of fruit and vegetables on insulin resistance in people at high risk of cardiovascular disease: a randomized controlled trial // Diabetes Care. 2013; 36: 3888-3896.

28. McCall D. O., McGartland C. P., McKinley M. C. et al. The effect of increased dietary fruit and vegetable consumption on endothelial activation, inflammation and oxidative stress in hypertensive volunteers // Nutr Metab Cardiovasc Dis. 2011; 21: 658-664.

29. Soares de Oliveira Carvalho A. P., Kimi Uehara S., Nogueria Netto J. F. et al. Hypocaloric diet associated with the consumption of jam enriched with microencapsulated fish oil decreases insulin resistance // Nutr Hosp. 2014; 29: 1103-1108.

30. Lee T. C., Ivester P., Hester A. G. et al. The impact of polyunsaturated fatty acid based dietary supplements on disease biomarkers in a metabolic syndrome/diabetes population // Lipids Health Dis. 2014; 13: 196.

31. Balfego M., Canivell S., Hanzu F. A. et al. Effects of sardine-enriched diet on metabolic control, inflammation and gut microbiota in drug-naive patients with type 2 diabetes: a pilot randomized trial // Lipids Health Dis. 2016; 15: 78.

32. Simao A. N., Lozovoy M. A., Bahls L. D. et al. Blood pressure decrease with ingestion of a soya product (kinako) or fish oil in women with the metabolic syndrome: role of adiponectin and nitric oxide // Br J Nutr. 2012; 108: 1435-1442.

33. Norat T., Bowman R., Luben R. et al. Blood pressure and interactions between the angiotensin polymorphism AGT M235T and sodium intake: a cross-sectional population study // Am J Clin Nutr. 2008; 88: 392-397.

34. Oh S. W., Han K. H., Han S. Y. et al. Association of sodium excretion with metabolic syndrome, insulin resistance, and body fat // Medicine (Baltimore). 2015; 94: e1650.

35. Oh Y. S., Appel L. J., Galis Z. S. et al. National Heart, Lung, and Blood Institute Working Group report on salt in human health and sickness: building on the current scientific evidence // Hypertension. 2016; 68: 281-288.

36. Chen J., Gu D., Huang J. et al. Metabolic syndrome and salt sensitivity of blood pressure in non-diabetic people in China: a dietary intervention study // Lancet. 2009; 373: 829-835.

37. Malaguarnera M., Gargante M. P., Russo C. et al. L-carnitine supplementation to diet: a new tool in treatment of nonalcoholic steatohepatitis - a randomized and controlled clinical trial // Am J Gastroenterol. 2010; 105: 1338-1345.

38. Musso G., Gambino R., Cassader M. et al. A meta-analysis of randomized trials for the treatment of nonalcoholic fatty liver disease // Hepatology. 2010; 52: 79-104.

39. Guerrerio A. L., Colvin R. M., Schwartz A. K. et al. Choline intake in a large cohort of patients with nonalcoholic fatty liver disease // Am J Clin Nutr. 2012; 95: 892-900.

40. Yu D., Shu X. O., Xiang Y. B. et al. Higher dietary choline intake is associated with lower risk of nonalcoholic fatty liver in normal-weight Chinese women // J Nutr. 2014; 144: 2034-2040.

41. Despres J. P, Lemieux I., Bergeron J. et al. Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk // Arterioscler Thromb Vasc Biol. 2008; 28: 1039-1049.

42. Janiszewski P. M., Ross R. The utility of physical activity in the management of global cardiometabolic risk // Obesity (Silver Spring). 2009; 17 (suppl 3): S3-S14.

43. Li Y., Lee S., Langleite T. et al. Subsarcolemmal lipid droplet responses to a combined endurance and strength exercise intervention // Physiol Rep. 2014; 2: e12187.

44. Garaulet M., Madrid J. A. Chronobiological aspects of nutrition, metabolic syndrome and obesity // Adv Drug Deliv Rev. 2010; 62 (9-10): 967-978.

45. Sack R. L., Auckley D., Auger R. R. et al. Circadian rhythm sleep disorders: part I, basic principles, shift work and jet lag disorders. An American Academy of Sleep Medicine review // Sleep. 2007; 30: 1460-1483.

46. Dallmann R., Viola A. U., Tarokh L. et al. The human circadian metabolome // Proc Natl Acad Sci USA. 2012; 109: 2625-2629.

47. Garaulet M., Gomez-Abellan P. Timing of food intake and obesity: a novel association // Physiol Behav. 2014; 134: 44-50.

48. Bandin C., Scheer F. A., Luque A. J. et al. Meal timing affects glucose tolerance, substrate oxidation and circadian-related variables: A randomized, crossover trial // Int J Obes (Lond). 2015; 39: 828-833.

49. Broussard J. L., Ehrmann D. A., Van Cauter E. et al. Impaired insulin signaling in human adipocytes after experimental sleep restriction: a randomized, crossover study // Ann Intern Med. 2012; 157: 549-557.

50. Rubio-Sastre P., Gomez-Abellan P., Martinez-Nicolas A. et al. Evening physical activity alters wrist temperature circadian rhythmicity // Chronobiol Int. 2014; 31: 276-282.:


Для цитирования:

Ахмедов В.А., Мамедова Н.Ф. Немедикаментозные методы лечения и реабилитации пациентов с неалкогольной жировой болезнью печени. Лечащий Врач. 2019;(6):50.

For citation:

Akhmedov V.A., Mamedova N.F. Non-pharmacological methods of treatment and rehabilitation of patients with non-alcoholic fatty liver disease. Lechaschi Vrach. 2019;(6):50. (In Russ.)

Просмотров: 87

Creative Commons License
Контент доступен под лицензией Attribution-NonCommercial-NoDerivatives 4.0 International.

ISSN 1560-5175 (Print)
ISSN 2687-1181 (Online)